Filter News
Area of Research
News Topics
- (-) Coronavirus (14)
- (-) Partnerships (12)
- 3-D Printing/Advanced Manufacturing (27)
- Advanced Reactors (4)
- Artificial Intelligence (15)
- Big Data (10)
- Bioenergy (51)
- Biology (73)
- Biomedical (20)
- Biotechnology (13)
- Buildings (5)
- Chemical Sciences (35)
- Clean Water (14)
- Climate Change (43)
- Composites (11)
- Computer Science (34)
- Critical Materials (13)
- Cybersecurity (5)
- Decarbonization (25)
- Energy Storage (37)
- Environment (100)
- Exascale Computing (6)
- Frontier (6)
- Fusion (8)
- Grid (8)
- High-Performance Computing (24)
- Hydropower (8)
- Irradiation (1)
- Isotopes (13)
- ITER (1)
- Machine Learning (11)
- Materials (78)
- Materials Science (82)
- Mathematics (3)
- Mercury (7)
- Microscopy (34)
- Molten Salt (3)
- Nanotechnology (42)
- National Security (5)
- Net Zero (3)
- Neutron Science (36)
- Nuclear Energy (16)
- Physics (30)
- Polymers (18)
- Quantum Computing (3)
- Quantum Science (11)
- Renewable Energy (2)
- Security (3)
- Simulation (15)
- Space Exploration (2)
- Summit (11)
- Sustainable Energy (42)
- Transformational Challenge Reactor (3)
- Transportation (15)
Media Contacts
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Marc-Antoni Racing has licensed a collection of patented energy storage technologies developed at ORNL. The technologies focus on components that enable fast-charging, energy-dense batteries for electric and hybrid vehicles and grid storage.
A new paper published in Nature Communications adds further evidence to the bradykinin storm theory of COVID-19’s viral pathogenesis — a theory that was posited two years ago by a team of researchers at the Department of Energy’s Oak Ridge National Laboratory.
Researchers from ORNL, the University of Tennessee at Chattanooga and Tuskegee University used mathematics to predict which areas of the SARS-CoV-2 spike protein are most likely to mutate.
Five technologies invented by scientists at the Department of Energy’s Oak Ridge National Laboratory have been selected for targeted investment through ORNL’s Technology Innovation Program.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
The annual Director's Awards recognized four individuals and teams including awards for leadership in quantum simulation development and application on high-performance computing platforms, and revolutionary advancements in the area of microbial
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.